| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 1 | -81.9K | 100% | $10.00 | -$819K |
| Net | -1 | -81.9K | -100% | -$819K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Franklin M. Berger | Director | $7.85M | Mar 25, 2024 | ||
| Bvf Partners L P/Il | 10%+ Owner | $3.58M | Jul 11, 2022 | ||
| David Parkinson | Chief Executive Officer, Director | $657K | Mar 25, 2024 | ||
| Scott Requadt | Director | $300K | Mar 25, 2024 | ||
| Richard M. Glickman | Director | $212K | Apr 24, 2024 | ||
| Peter Virsik | Chief Operating Officer | $46.9K | -$819K | -94.6% | Oct 7, 2024 |
| Biotech Growth N V | 10%+ Owner | $0 | Nov 1, 2024 | ||
| Marella Thorell | Director | Mar 25, 2024 | |||
| Sanford Zweifach | Director | Mar 25, 2024 | |||
| Gary Sollis | Director | Mar 25, 2024 | |||
| John Alexander Martin | Director | Mar 25, 2024 | |||
| David Wood | Chief Financial Officer | Mar 25, 2024 | |||
| Philip W. Kantoff | Director | Mar 25, 2024 | |||
| Lauren Merendino | Director | Mar 25, 2024 | |||
| Alessandra Cesano | Chief Medical Officer | Mar 25, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|